Xeno Laboratories DHB 200 mg/ml Dihydroboldenone Cypionate

Yes. DHB is short for dihydroboldenone, and the same molecule is sold under the name 1-testosterone or 1-Test. Its structure is 17beta-hydroxy-5alpha-androst-1-en-3-one, which is a dihydrotestosterone skeleton with an additional double bond in the first ring. That single modification produces a markedly more androgenic compound than testosterone, and unlike boldenone it cannot be converted to estradiol.

No. The ring is already 5-alpha reduced, so aromatase has no substrate to act on and no estradiol is formed from this molecule. Water retention and breast tissue change are therefore not attributed to DHB itself. In any real block, though, the total hormonal picture is set by the whole combination, and an aromatising base ester in the same protocol produces the estrogen that dihydroboldenone does not.

Injection site pain is reported by a substantial share of users in vendor and community material, and this card states that as an observation rather than explaining it with a mechanism that no source provides. Higher concentration preparations are commonly described as more irritating. No published study measured pain scores for a 200 mg/ml preparation, so the practical point for a research setting is simply that this vial is known to be a painful one.

The androgenic load is the main theme: acne, hair shedding in predisposed users, and a fall in HDL with a rise in LDL in routine lipid panels. Injected androgens also suppress natural testosterone production, so recovery has to be planned. Animal work quoted in reference material records an increase in liver mass with this compound, a finding that has not been translated into a human liver signal and should not be read as one.

There is no registered human dose. Community material starts at the lowest end of the range and caps in the low hundreds of milligrams per week, split across two or three injections because of the ester, with a testosterone base supplying the aromatisation. Duration is usually described in weeks rather than months. These figures are community protocols quoted for completeness, not a recommendation, and the compound is not approved for human use.

This vial is listed as research material with international checkout and a U.S. domestic option. Orders are handled within one to two business days and every batch ships with an HPLC report and a Certificate of Analysis. Stock, variant and the current price are shown in the product block above; at the time of checking, the listing carried an out of stock marker while packs are restocked, so confirm the stock line before ordering.